Delivery Order SPE2DB20D7066-SPE2DB25FC4PM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 ml in 200 ml quantities, with a firm fixed price ceiling value of $1,908.72. The contract, which is a non-set-aside competitive award with an ultimate completion date of June 6, 2025, is performed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL) with a ceiling value of $3,342.70 and an ultimate completion date of July 1, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 and extends through...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% 400 mg/200 ml in 200 ml quantities, with a ceiling value of $9,384.67 and a firm fixed price structure. The contract was competitively awarded without any set-aside designation and is scheduled for completion by August 7, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,790.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL vials). The contract, which is a non-set-aside competitive award with an ultimate completion date of July 28, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order will be fulfilled from the vendor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ropivacaine 0.2% 200 mg/100 ml in 100 ml quantities, with a contract ceiling value of $5,432.13 and an ultimate completion date of September 10, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $3,428.19 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml in 200 ml units). This firm fixed-price delivery order is scheduled for completion by June 20, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation, reflecting the vendor's established capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% in a 400 mg/200 mL concentration with a ceiling value of $1,529.13. This competitive, firm fixed-price delivery order was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Ropivacaine is a local anesthetic used in medical and surgical procedures, and this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL) in 200 mL quantities, with a contract ceiling value of $3,419.59. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement channels. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a $2,477.82 delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml), a local anesthetic pharmaceutical product. This firm fixed price contract, with an ultimate completion date of June 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ropivacaine 0.2% in a 400 mg/200 ml dosage format. This firm fixed-price delivery order, valued at $2,818.62, represents a non-competitive set-aside procurement and is scheduled for completion by June 20, 2025, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. The award is issued as a child contract under...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4PMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% 200 mg/100 mL in 100 mL units under a firm fixed-price contract valued at $2,201.74. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025, with no set-aside designation applied. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 through December 2026. Ropivacaine is a local anesthetic commonly used in medical and surgical procedures, making this procurement consistent with the Defense Logistics Agency's mission to supply pharmaceutical products and medical commodities to support military healthcare operations worldwide. AmerisourceBergen Drug Corp has demonstrated its capability to meet federal procurement requirements through numerous competitive awards across its comprehensive pharmaceutical and medical supplies portfolio, which includes specialty medications, generic and brand-name drugs, and medical devices. The competitive award of this delivery order reflects the vendor's established standing as a critical supplier within the federal medical supply chain serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/3/25 |